The agency is missing deadlines and not responding to biotech companies, forcing some to push back clinical trials.

Let's look at why this news could be a game-changer for Eli Lilly and its stock.

The FDA has issued a warning about counterfeit Ozempic medications, sharing the lot numbers and serial numbers of products ...

Many of the directions included in the order will be familiar to those who watched drug pricing policy closely during the ...

While Food and Drug Administration inspectors who make sure food and drugs meet quality standards were spared in recent cuts, ...

The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...

President Trump directed his administration to help states import drugs from Canada. But a proposal to alter a Medicare ...

The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to ...

The order calls for lowering the price of insulin for low-income patients or people who are uninsured, as well as lowering ...

A new executive order signed Tuesday by President Trump directs Congress to change a key provision of the law allowing ...